Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
Joint Authors
Al-Saiegh, Yousif
Spears, Jenna
Lee, Christopher
Chetrit, David Alexandre
Manthey, Sina
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-02-27
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Apixaban is a rare cause of leukocytoclastic vasculitis (LCV).
To our knowledge, there is only one other reported case due to apixaban in the literature.
We present a case of apixaban-induced leukocytoclastic vasculitis in a 95-year-old male.
He had been started on apixaban 12 days prior to presentation and developed worsening palpable purpura of his lower extremities.
Possible etiologies of this new rash were excluded, with biopsy showing extensive purpura with superficial perivascular neutrophilic infiltrate and leukocytoclasis.
Apixaban was discontinued, and the patient was started on a slow prednisone taper with subsequent resolution of his rash.
American Psychological Association (APA)
Spears, Jenna& Chetrit, David Alexandre& Manthey, Sina& Lee, Christopher& Al-Saiegh, Yousif. 2020. Apixaban as a Rare Cause of Leukocytoclastic Vasculitis. Case Reports in Rheumatology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1151171
Modern Language Association (MLA)
Spears, Jenna…[et al.]. Apixaban as a Rare Cause of Leukocytoclastic Vasculitis. Case Reports in Rheumatology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1151171
American Medical Association (AMA)
Spears, Jenna& Chetrit, David Alexandre& Manthey, Sina& Lee, Christopher& Al-Saiegh, Yousif. Apixaban as a Rare Cause of Leukocytoclastic Vasculitis. Case Reports in Rheumatology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1151171
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1151171
